New drugs being developed for neurosteroidogenesis (aside from SAGE-217)

Hi, I just found this. Seems further down the line than even Zuranolone though.


From a cursory look, it’s etifoxine with a better safety profile and lower/less frequent dosing.

Perhaps this means we’re witnessing a new trend in psychiatry as neurosteroids may be the next gold rush for big pharma?

1 Like

And another one, in the form of a spray for MDD.


Hoping that we’re about to arrive at a watershed in psychiatry. Also VTGN chart seems to have bottomed out. What is stock dilution though? Seems like a good entry if you’re a gambler.